首页> 外文期刊>Microbiology >Macrophage-specific Mycobacterium tuberculosis genes: identification by green fluorescent protein and kanamycin resistance selection
【24h】

Macrophage-specific Mycobacterium tuberculosis genes: identification by green fluorescent protein and kanamycin resistance selection

机译:巨噬细胞特异性结核病基因:绿色荧光蛋白和卡那霉素抵抗选择的鉴定

获取原文
           

摘要

Mycobacterium tuberculosis survives and multiplies inside macrophages of its host by modulating the expression of several genes essential for in vivo survival. An in vivo expression system has been developed, based on green fluorescent protein and kanamycin resistance, to identify M. tuberculosis genes which appear to be up-regulated in infected macrophages. A promoter-trap shuttle vector, pLL192, was constructed, containing a streptomycin resistance gene as selection marker and an artificial bicistronic operon composed of the promoterless green fluorescent protein (gfp) gene, followed by the kanamycin resistance gene. A unique BamHI site upstream of the gfp gene allowed for insertion of promoter libraries. The vector was validated by the use of known regulated or constitutive M. tuberculosis promoters. In addition, an M. tuberculosis genomic DNA library was inserted into pLL192 and then introduced into Mycobacterium bovis BCG. The recombinant BCG cells were then used to infect the J774A.1 murine macrophage-like cell line in the presence of kanamycin. Several recombinant BCG cells were thereby selected that were resistant to kanamycin within infected macrophages, but were sensitive to kanamycin when grown in vitro. The kanamycin resistance phenotype was paralleled by the fluorescence phenotype. After nucleotide sequencing, the corresponding genes were identified as mce1A, PE_PGRS63(RV3097c), Rv2232, Rv1026, Rv1635c, viuB, Rv2231(cobC) and Rv0997. Real-time PCR analysis using RNA isolated at various time points from M. tuberculosis and M. bovis BCG grown in vitro and within macrophages, confirmed the up-regulation of these genes. The level of up-regulation varied from 2- to 40-fold in macrophages compared to growth in vitro.
机译:通过调节体内存活中必需的几种基因的表达,分枝杆菌血栓分枝杆菌病毒杂交和倍增。基于绿色荧光蛋白和卡那霉素抗性,已经开发了体内表达系统,以鉴定似乎在感染的巨噬细胞上调上调的结核病基因。构建了促进者 - 捕获梭载体PLL192,含有链霉素抗性基因作为选择标记和由促进剂的绿色荧光蛋白(GFP)基因组成的人工双顺反应序列,其次是Kanamycin抗性基因。在GFP基因上游的独特BamHI位点允许插入启动子文库。通过使用已知的调节或组分M.结核分枝杆菌启动子验证载体。此外,将肺结核基因组DNA文库插入PLL192中,然后将其引入细胞杆菌BCG中。然后使用重组BCG细胞在卡那霉素存在下感染J774A.1鼠巨噬细胞样细胞系。由此选择几种重组BCG细胞,其在感染的巨噬细胞内抵抗卡那霉素,但在体外生长时对卡那霉素敏感。卡那霉素抵抗表型被荧光表型平行于荧光表型。在核苷酸测序后,将相应的基因鉴定为MCE1a,PE_pgrs63(RV3097c),RV2232,RV1026,RV1635C,VIUB,RV2231(COBC)和RV0997。实时PCR分析使用RNA分离在来自M.结核病和M. Bovis BCG在体外和巨噬细胞内生长的M. Bovis BCG的不同时间点,证实了这些基因的上调。与体外生长相比,上调水平从巨噬细胞的2-至40倍变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号